| ²é¿´: 432 | »Ø¸´: 2 | |||
ryz8580ľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
Çó½â~À´ÄǶȰ·---ÉÏÊÐÖÆ¼ÁÇé¿ö
|
| ÄÇλ֪µÀÀ´ÄǶȰ·½ºÄÒÊÐÊÛÆ·µÄÏà¹ØÇé¿ö£¿¾ÍÊǸ÷¹æ¸ñ¶ÔÓ¦½ºÄÒ´óС£¬ÄÚÈÝÎïÖØµÈ£¬Íò·Ö¸Ðл£¡ |
» ²ÂÄãϲ»¶
CSC¸ÄÅÉ-²©Ê¿Éú½»Á÷·Ãѧ
ÒѾÓÐ19È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ154È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ1È˻ظ´
°ÍÀèÈø¿ËÀ×´óѧÓë¹ú¼ÒÁôѧ»ù½ðίºÏ×÷²©Ê¿Ñо¿ÉúÏîÄ¿-Ö¬ÖÊÄÉÃ×Ò©Îï/ÉúÎï²ÄÁÏ/¶à·ÓµÝËÍ
ÒѾÓÐ10È˻ظ´
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ2È˻ظ´
26É격×Ô¼ö
ÒѾÓÐ12È˻ظ´
SUES&NERCN¿ÎÌâ×é½ÓÊÜ˶ʿÉúµ÷¼Á (ѧ˶1Ãû+ר˶1Ãû)
ÒѾÓÐ0È˻ظ´
SUES&NERCN¿ÎÌâ×é½ÓÊÜ˶ʿÉúµ÷¼Á (ѧ˶1Ãû+ר˶1Ãû)
ÒѾÓÐ0È˻ظ´
fish0540110
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 4419.2
- ºì»¨: 2
- Ìû×Ó: 77
- ÔÚÏß: 164.3Сʱ
- ³æºÅ: 548974
- ×¢²á: 2008-04-20
- ÐÔ±ð: GG
- רҵ: Ò©¼Áѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ryz8580: »ØÌûÖö¥ 2012-07-24 17:33:40
ryz8580: ½ð±Ò+20, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-07-24 17:34:43
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, ллÌṩ£¬»¶Ó³£À´Å¶¡£ 2012-07-24 18:09:32
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ryz8580: »ØÌûÖö¥ 2012-07-24 17:33:40
ryz8580: ½ð±Ò+20, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸ 2012-07-24 17:34:43
³ÕÒÄ×ÓÆ¤: ½ð±Ò+2, ллÌṩ£¬»¶Ó³£À´Å¶¡£ 2012-07-24 18:09:32
|
¸øÄãÒ»¸öÃ÷È·µÄ´ð°¸°É£¬Õⲿ·ÖÓ¢ÎÄÕª×ÔÔÑй«Ë¾ÉÏÊÐÆ·ËµÃ÷Êé¡£ The empirical formula for lenalidomide is C13H13N3O3, and the gram molecular weight is 259.3. Lenalidomide is an off-white to pale-yellow solid powder. It is soluble in organic solvent/water mixtures, and buffered aqueous solvents. Lenalidomide is more soluble in organic solvents and low pH solutions. Solubility was significantly lower in less acidic buffers, ranging from about 0.4 to 0.5 mg/ml. Lenalidomide has an asymmetric carbon atom and can exist as the optically active forms S(-) and R(+), and is produced as a racemic mixture with a net optical rotation of zero. REVLIMID is available in 5 mg, 10 mg, 15 mg and 25 mg capsules for oral administration. Each capsule contains lenalidomide as the active ingredient and the following inactive ingredients: lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate. The 5 mg and 25 mg capsule shell contains gelatin, titanium dioxide and black ink. The 10 mg capsule shell contains gelatin, FD&C blue #2, yellow iron oxide, titanium dioxide and black ink. The 15 mg capsule shell contains gelatin, FD&C blue #2, titanium dioxide and black ink.£¨Õâ¶ÎÖ¸µÄÊǸ÷¸¨ÁϵÄÖÖÀ࣬¹æ¸ñÒ²¾ÍÓÐÁË£© µ±È»Ç°ÃæÖ»Êdzõ¼¶°àµÄË®×¼¡£ ÏÂÃæ¸øÄã¾ßÌåµÄһЩ¸üÓÐÓÃÐÅÏ¢£º 5mg¹æ¸ñ´¦·½ÈçÏ£º Ingredient Name Strength ANHYDROUS LACTOSE 147 mg CELLULOSE, MICROCRYSTALLINE 40 mg CROSCARMELLOSE SODIUM 6 mg MAGNESIUM STEARATE 2 mg CAPSULE Size 18mm 10mg¹æ¸ñ´¦·½ÈçÏ£º Ingredient Name Strength ANHYDROUS LACTOSE 294 mg CELLULOSE, MICROCRYSTALLINE 80 mg CROSCARMELLOSE SODIUM 12 mg MAGNESIUM STEARATE 4 mg CAPSULE Size 22mm 15ÃÀ¹ú¹æ¸ñ´¦·½ÈçÏ£º Ingredient Name Strength ANHYDROUS LACTOSE 289 mg CELLULOSE, MICROCRYSTALLINE 80 mg CROSCARMELLOSE SODIUM 12 mg MAGNESIUM STEARATE 4 mg CAPSULE Size 22mm 25mg¹æ¸ñ´¦·½ÈçÏ£º Ingredient Name Strength ANHYDROUS LACTOSE 200 mg CELLULOSE, MICROCRYSTALLINE 159 mg CROSCARMELLOSE SODIUM 12 mg MAGNESIUM STEARATE 4 mg CAPSULE Size 22mm ´¦·½ÒÔ¼°½ºÄÒ´óСÒѾÂÞÁÐÍê±Ï£¬Ô¸ÄãÔçÈÕÍê³ÉÏîÄ¿ ![]() |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
2Â¥2012-07-24 15:15:03
ryz8580
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 3050.6
- É¢½ð: 796
- ºì»¨: 3
- ɳ·¢: 1
- Ìû×Ó: 306
- ÔÚÏß: 1053.3Сʱ
- ³æºÅ: 573134
- ×¢²á: 2008-06-13
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢
3Â¥2012-07-24 17:34:04














»Ø¸´´ËÂ¥
ryz8580